John Russel Denton

CIK: 0002071923

Transaction Breakdown

Open Market Buys (P)2 (25.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (37.5%)

Compensation grants

Other (G, F, J, C, D, …)2 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CAI

Caris Life Sciences, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

CAI
Caris Life Sciences, Inc.
Sep 22, 2026
Sale(S)
Direct
7.5K shares at avg. $31.82$239K
CAI
Caris Life Sciences, Inc.
May 15, 2026
Tax Payment(F)
Direct
6K shares at avg. $15.25$92K
CAI
Caris Life Sciences, Inc.
Mar 6, 2026
Award(A)
Direct
64K shares-
CAI
Caris Life Sciences, Inc.
Nov 7, 2025
Purchase(P)
Indirect
4.2K shares at avg. $24.09$101K
CAI
Caris Life Sciences, Inc.
Jun 20, 2025
Purchase(P)
Direct
7.5K shares at avg. $21.00$158K
CAI
Caris Life Sciences, Inc.
Jun 18, 2025
Award(A)
Direct
99.3K shares-
CAI
Caris Life Sciences, Inc.
Mar 3, 2025
Disposition(D)
Direct
238.2K shares at avg. $18.60$4.4M
CAI
Caris Life Sciences, Inc.
Mar 3, 2025
Award(A)
Stock Option
Direct
255K shares-

		Type	Shares	Price		Ownership
Sep 22, 2026	CAI Caris Life Sciences, Inc.	Sale(S)	7,500	$31.82	$238,626	Direct
May 15, 2026	CAI Caris Life Sciences, Inc.	Tax Payment(F)	6,047	$15.25	$92,217	Direct
Mar 6, 2026	CAI Caris Life Sciences, Inc.	Award(A)	63,971	-	$0	Direct
Nov 7, 2025	CAI Caris Life Sciences, Inc.	Purchase(P)	4,184	$24.09	$100,793	Indirect
Jun 20, 2025	CAI Caris Life Sciences, Inc.	Purchase(P)	7,500	$21.00	$157,500	Direct
Jun 18, 2025	CAI Caris Life Sciences, Inc.	Award(A)	99,321	-	-	Direct
Mar 3, 2025	CAI Caris Life Sciences, Inc.	Disposition(D)	238,230	$18.60	$4,431,078	Direct
Mar 3, 2025	CAI Caris Life Sciences, Inc.	Award(A) Stock Option	255,000	-	-	Direct

1-8 of 8 transactions

About Denton John Russel

Denton John Russel (SEC CIK 0002071923) files insider reports with the SEC as Officer of Caris Life Sciences, Inc. (CAI).

Signal8 holds 6 ownership filings by Denton John Russel (1 Form 3, 5 Form 4), filed between Jun 17, 2025 and Sep 23, 2026. Those filings report 8 transactions, from Mar 3, 2025 to Sep 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Denton John Russel's filings is in IRVING, TX.

Recent filings by Denton John Russel

Sep 22, 2026: Open-market sale of CAI shares (Form 4, code S).
May 15, 2026: Tax withholding of CAI shares (Form 4, code F).
Mar 6, 2026: Grant or award of CAI shares (Form 4, code A).
Nov 7, 2025: Open-market purchase of CAI shares (Form 4, code P).
Jun 20, 2025: Open-market purchase of CAI shares (Form 4, code P).

Other insiders filing for Caris Life Sciences, Inc. (CAI)

How to read Form 4 transaction codes